The Joint Corp. (NASDAQ:JYNT – Get Free Report) major shareholder Charles Jobson acquired 10,000 shares of the stock in a transaction dated Friday, December 5th. The shares were purchased at an average cost of $8.41 per share, with a total value of $84,100.00. Following the completion of the purchase, the insider owned 1,615,027 shares of the company’s stock, valued at approximately $13,582,377.07. The trade was a 0.62% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
Joint Stock Performance
Shares of NASDAQ JYNT traded up $0.08 during trading hours on Tuesday, hitting $8.72. The company’s stock had a trading volume of 69,848 shares, compared to its average volume of 75,838. The business has a 50-day simple moving average of $8.39 and a 200-day simple moving average of $10.07. The stock has a market cap of $129.63 million, a price-to-earnings ratio of -145.31 and a beta of 1.30. The Joint Corp. has a 12 month low of $7.50 and a 12 month high of $13.47.
Joint (NASDAQ:JYNT – Get Free Report) last issued its quarterly earnings data on Friday, November 7th. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. Joint had a negative return on equity of 0.98% and a negative net margin of 1.78%.The firm had revenue of $13.38 million for the quarter, compared to analyst estimates of $13.36 million. On average, equities research analysts forecast that The Joint Corp. will post 0.11 EPS for the current year.
Hedge Funds Weigh In On Joint
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the stock. B. Riley lowered shares of Joint from a “buy” rating to a “hold” rating in a research note on Friday, November 7th. Weiss Ratings restated a “sell (e+)” rating on shares of Joint in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $17.00.
View Our Latest Stock Report on JYNT
Joint Company Profile
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Recommended Stories
- Five stocks we like better than Joint
- What Investors Need to Know About Upcoming IPOs
- Anheuser-Busch Buys BeatBox to Win Over Younger Drinkers
- Why Invest in 5G? How to Invest in 5G Stocks
- Office Suite Gets Pricier: Microsoft’s Bold Move Comes With Risk
- 3 Best Fintech Stocks for a Portfolio Boost
- Big Blue’s Big Bet: IBM Buys AI Nervous System for $11B
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.
